National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

PI3K delta inhibitor CAL-101
A small molecule inhibitor of the delta isoform of the 110 kDa catalytic subunit of class IA phosphoinositide-3 kinases (PI3K) with potential immunomodulating and antineoplastic activities. PI3K-delta inhibitor CAL-101 inhibits the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), preventing the activation of the PI3K signaling pathway and thus inhibiting tumor cell proliferation, motility, and survival. Unlike other isoforms of PI3K, PI3K-delta is expressed primarily in hematopoietic lineages. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:phosphoinositide-3 kinase delta inhibitor CAL-101
Code name:CAL-101



Previous:phosphorus P32, Photochlor, Photofrin, phytochemical, PI-88
Next:PI3K inhibitor BEZ235, PI3K inhibitor BGT226, PI3K inhibitor GSK1059615, PI3K inhibitor PX-866, PI3K/mTOR dual kinase inhibitor XL765

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov